• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST Back to Search Results
Model Number 100071
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems Bruise/Contusion (1754); Test Result (2695)
Event Date 06/07/2016
Event Type  Injury  
Manufacturer Narrative
Investigation conclusion: investigation pending.
 
Event Description
Report received of discrepant inratio values.Patient's therapeutic range = 3.5 - 4.5.On (b)(6) 2016 inratio inr = 7.5.On (b)(6) 2016 inratio inr = 7.5 due to patient's high results, she was taken off coumadin.Her usual dose of coumadin is 3.5mg/day.On (b)(6) 2016 inratio inr = >7.5.On (b)(6) 2016 hospital lab inr = 20.43 (time unknown).On (b)(6) 2016 in response to the last high inratio result from (b)(6) 2016 of >7.5, patient self tester was admitted to (b)(6) hospital.A venous blood draw lab test was performed and resulted in inr = 20.43.Exact time of lab test was not specified by patient.Patient's physician also administered a one-time, unspecified antibiotic - dose unknown.Patient was treated with plasma infusions and as of (b)(6) 2016 was currently still in the hospital and had not been discharged.Patient stated that her body was covered in bruises and that she had over 25 bruise spots on her "arms and legs alone." the inratio product has a maximum reporting range of >7.5.This adverse event is being conservatively filed.
 
Manufacturer Narrative
Investigation/conclusion: it is indicated that the product is not returning for evaluation.Therefore, a review of the entire in-house testing history of the reported lot was performed.In-house strip testing on the reported strip lot meets accuracy criteria.The product performed as expected and no product deficiency was identified.Although a relevant nc was noted in batch record, it did not affect the final release specifications.There is no indication of a product deficiency and additional corrective actions were not required.The customer did not provide a lab comparative for the reported inratio results of 7.5 from (b)(6).It is not possible to verify if a discrepancy exists without this information.The customer reported an unexpected high inratio inr result of >7.5 on (b)(6) 2016.An inr result greater than the measurable range will result in an inr value of >7.5.Root cause could not be determined from the information provided by the customer.Capa-(b)(4) was initiated to investigate the cause of highly discrepant results.Further investigation into this issue is being performed under capa-(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INRATIO PT/INR TEST STRIPS
Type of Device
PROTHROMBIN TIME TEST
Manufacturer (Section D)
ALERE SAN DIEGO, INC.
9975 summers ridge road
san diego CA 92121
Manufacturer Contact
ya-ling king
9975 summers ridge road
san diego, CA 92121
8588052084
MDR Report Key5780580
MDR Text Key49129206
Report Number2027969-2016-00502
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K092987
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,other
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 06/10/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model Number100071
Device Lot Number387627A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 06/10/2016
Initial Date FDA Received07/09/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received07/15/2016
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-